| I-14 Alessandro Di Deo Evaluation of the pharmacokinetics of tideglusib in congenital and childhood myotonic dystrophy type 1 using Bayesian priors Wednesday 09:45-11:15 |
| I-14 Alessandro Di Deo Evaluation of the pharmacokinetics of tideglusib in congenital and childhood myotonic dystrophy type 1 using Bayesian priors Wednesday 09:45-11:15 |